Disease Management Programs for Type 2 Diabetes in Germany
Open accessAbstract
BACKGROUND: Disease management programs (DMPs) are intended to improve the care of persons with chronic diseases. Despite numerous studies there is no unequivocal evidence about the effectiveness of DMPs in Germany. METHOD: We conducted a systematic literature review in the MEDLINE, EMBASE, Cochrane Library, and CCMed databases. Our analysis included all controlled studies in which patients with type 2 diabetes enrolled in a DMP were compared to type 2 diabetes patients receiving routine care with respect to process, outcome, and economic parameters. RESULTS: The 9 studies included in the analysis were highly divergent with respect to their characteristics and the process and outcome parameters studied in each. No study had data beyond the year 2008. In 3 publications, the DMP patients had a lower mortality than the control patients (2.3%, 11.3%, and 7.17% versus 4.7%, 14.4%, and 14.72%). In 2 publications, DMP participation was found to be associated with a mean survival time of 1044.94 (± 189.87) days, as against 985.02 (± 264.68) in the control group. No consistent effect was seen with respect to morbidity, quality of life, or economic parameters. 7 publications from 5 studies revealed positive effects on process parameters for DMP participants. CONCLUSION: The observed beneficial trends with respect to mortality and survival time, as well as improvements in process parameters, indicate that DMPs can, in fact, improve the care of patients with diabetes. Further evaluation is needed, because some changes in outcome parameters (an important indicator of the quality of care) may only be observable over a longer period of time.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,019 · see citing works
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,769 · see citing works
Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568 · see citing works
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,494 · see citing works
The effectiveness of disease and case management for people with diabetesA systematic review
Norris, S. L., Nichols, P., Caspersen, C. J., Glasgow, R. E., Engelgau, M. M., Jack, L., Isham, G. J., SNYDER, S., Carande-Kulis, V. G., & GARFIELD, S. A. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00423-3 · Cited by 496 · see citing works
Ofman, J. J., Badamgarav, E., Henning, J. M., Knight, K. K., Gano, A. D., Levan, R. K., Gur-Arie, S., Richards, M. S., Hasselblad, V., & Weingarten, S. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.018 · Cited by 291 · see citing works
Tackling Chronic Disease in Europe: Strategies, Interventions and Challenges
Busse, R. (2010) · Cited by 285 · see citing works
Self-citationEffectiveness of disease-management programs for improving diabetes care: a meta-analysis
Pimouguet, C., Goff, M. L., Thiébaut, R., Jf, D., & Helmer, C. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091786 · Cited by 276 · see citing works
Evidence for the effect of disease management: is $1 billion a year a good investment?
Mattke, S., Seid, M., & Ma, S. (2007) · PubMed · Cited by 216 · see citing works
A systematic review of diabetes disease management programs.
Knight, K. K., Badamgarav, E., Henning, J. M., Hasselblad, V., Gano, A. D., Ofman, J. J., & Weingarten, S. R. (2005) · PubMed · Cited by 189 · see citing works
Disease Management Programs In Germany’s Statutory Health Insurance System
Busse, R. (2004) · Health Affairs · doi:10.1377/hlthaff.23.3.56 · Cited by 187 · see citing works
Self-citationPrävalenz und zeitliche Entwicklung des bekannten Diabetes mellitus
Heidemann, C., Du, Y., Schubert, I., Rathmann, W., & Scheidt‐Nave, C. (2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1662-5 · Cited by 172 · see citing works
Prävalenz und zeitliche Entwicklung des bekannten Diabetes mellitus
Heidemann, C., Du, Y., Schübert, I., Rathmann, W., & Scheidt‐Nave, C. (2013) · Publication server of the Robert Koch Institute (Robert Kock Institute) · Cited by 160 · see citing works
Szécsényi, J., Rosemann, T. J., Joos, S., Peters-Klimm, F., & Miksch, A. (2008) · Diabetes Care · doi:10.2337/dc07-2104 · Cited by 138 · see citing works
German Diabetes Management Programs Improve Quality Of Care And Curb Costs
Stock, S., Drabik-Chamerska, A., Büscher, G., Graf, C. A., Ullrich, W., Gerber, A., Lauterbach, K. W., & Lüngen, M. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0799 · Cited by 127 · see citing works
de Bruin, S. R., Heijink, R., Lemmens, L. C., Struijs, J. N., & Baan, C. A. (2011) · Health Policy · doi:10.1016/j.healthpol.2011.03.006 · Cited by 111 · see citing works
Care management for Type 2 diabetes in the United States: a systematic review and meta-analysis
Egginton, J. S., Ridgeway, J. L., Shah, N. D., Balasubramaniam, S. C., Emmanuel, J. R., Prokop, L. J., Montori, V. M., & Murad, M. H. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-72 · Cited by 76 · see citing works
Is there a survival benefit within a German primary care-based disease management program?
Miksch, A., Laux, G., Ose, D. J., Joos, S., Campbell, S., Riens, B., & Szécsényi, J. (2010) · PubMed · Cited by 73 · see citing works
The Benefit and Efficiency of the Disease Management Program for Type 2 Diabetes
Linder, R., Ahrens, S., Köppel, D., Heilmann, T., & Verheyen, F. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0155 · Cited by 66 · see citing works
Fortschreibung der KoDiM-Studie: Kosten des Diabetes mellitus 2000–2009
Köster, I., Schübert, I., & Huppertz, E. (2012) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0032-1304891 · Cited by 61 · see citing works
Schäfer, I., Küver, C., Gedrose, B., Hoffmann, F., Ruß-Thiel, B., Brose, H.-P., van den Bussche, H., & Kaduszkiewicz, H. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-55 · Cited by 48 · see citing works
Stark, R. G., Schunk, M. V., Meisinger, C., Rathmann, W., Leidl, R., Holle, R., & for the KORA Study Group (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1186 · Cited by 34 · see citing works
Ose, D. J., Miksch, A., Urban, E., Natanzon, I., Szécsényi, J., Kunz, C. U., & Freund, T. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-179 · Cited by 34 · see citing works
Disease Management Evaluation: A Comprehensive Review of Current State of the Art.
Conklin, A., & Nolte, E. (2011) · PubMed · Cited by 32 · see citing works
Qualität der Versorgung chronisch Kranker in Deutschland
Fullerton, B., Nolte, E., & Erler, A. (2011) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2010.12.025 · Cited by 27 · see citing works
Drabik, A., Büscher, G., Thomas, K., Graf, C. A., Müller, D., & Stock, S. (2012) · Population Health Management · doi:10.1089/pop.2011.0063 · Cited by 25 · see citing works
Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective
Drabik, A., Büscher, G., Sawicki, P. T., Thomas, K., Graf, C. A., Müller, D., & Stock, S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.09.015 · Cited by 22 · see citing works
Das deutsche Gesundheitssystem
Busse, R., Blümel, M., & Spranger, A. (2017) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954662623 · Cited by 20 · see citing works
Self-citationDrabik, A., Sawicki, P. T., Müller, D. T., Passon, A. M., & Stock, S. (2012) · Das Gesundheitswesen · doi:10.1055/s-0031-1301273 · Cited by 15 · see citing works
Drabik, A., Graf, C. A., Büscher, G., et al. (2012) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2011.12.007 · Cited by 14 · see citing works
Elkeles, T., Kirschner, W., Graf, C. A., et al. (2008) · Journal of Public Health · doi:10.1007/s10389-008-0234-5 · Cited by 14 · see citing works
Nolte, E., & Hinrichs, S. (2012) · Cited by 13 · see citing works
Nolting, H.-D., Gottberg, A., Schiffhorst, G., et al. (2011) · Gesundheitsökonomie & Qualitätsmanagement · doi:10.1055/s-0029-1245920 · Cited by 11 · see citing works
Methodische Ansätze in der Versorgungsforschung
Morfeld, M., & Wirtz, M. A. (2006) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-005-1204-5 · Cited by 10 · see citing works
[Evaluation of disease management programs--current deficits, demands and methods].
Gerlach, F. M., Beyer, M., Szécsényi, J., & Raspe, H. H. (2003) · PubMed · Cited by 10 · see citing works
Ose, D. J., Freund, T., Urban, E., Kunz, C. U., Szécsényi, J., & Miksch, A. (2011) · Journal of Public Health · doi:10.1007/s10389-011-0429-z · Cited by 9 · see citing works
Miksch, A., Hermann, K., Trieschmann, J., et al. (2008) · Das Gesundheitswesen · doi:10.1055/s-2008-1077057 · Cited by 9 · see citing works
Graf C, Elkeles T, Kirschner W. „Gibt es einen Selektionsbias im DMP Diabetes? ...“
(2009) · Zeitschrift für Allgemeinmedizin · doi:10.1007/bf03653001 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757 · see citing works
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany
Kähm, K., Laxy, M., Schneider, U., Rogowski, W. H., Lhachimi, S. K., & Holle, R. (2018) · Diabetes Care · doi:10.2337/dc17-1763 · Cited by 141 · see citing works
Mehring, M., Donnachie, E., Bonke, F. C., Werner, C., & Schneider, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0236-y · Cited by 26 · see citing works
Bretschneider, M. P., Kolasińska, A. B., Šomvárska, L., Klásek, J., Mareš, J., & Schwarz, P. E. (2025) · Journal of Medical Internet Research · doi:10.2196/68648 · Cited by 15 · see citing works
“Similarly, the disease management program for type 2 diabetes patients, launched in Germany in 2002, despite its positive impact on quality of care [17-19], does not guarantee patients’ active involvement in the disease management in-between medical check-ups.”
- Authors
- Fuchs, S., Henschke, C., Blümel, M., & Busse, R.
- Affiliations
- Technische Universität Berlin (DE)
- Corresponding author
- Fuchs, Sabine
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2014-06-27
- Volume
- 111
- Issue
- 26
- Pages
- 453-63
- ISSN
- 1866-0452 (ISSN-L)
- PMC
- PMC4101529
- OpenAlex
- W2327041381
- Cited by
- 102
- References
- 38
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 1 · 2023: 7 · 2022: 6 · 2021: 16 · 2020: 10 · 2019: 8 · 2018: 12 · 2017: 13 · 2016: 12 · 2015: 10 · 2014: 1
- FWCI
- 1.91
- Type
- journal article
- Language
- de
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Deutsches Ärzteblatt international (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- disease management programs, type 2 diabetes, diabetes management, mortality, survival time, quality of care, process parameters, economic outcomes, quality of life, morbidity
- MeSH terms
- Aged, Chronic Disease, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Germany, Humans, Middle Aged, Risk Factors, Program Evaluation, Prevalence, Survival Rate, Treatment Outcome, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
